Hisaka A - Search Results

1

Analysis and prediction of drug transfer into human milk taking into consideration secretion and reuptake clearances across the mammary epithelia.

Koshimichi H, Ito K, Hisaka A, Honma M, Suzuki H. Koshimichi H, et al. Among authors: hisaka a. Drug Metab Dispos. 2011 Dec;39(12):2370-80. doi: 10.1124/dmd.111.040972. Epub 2011 Sep 22. Drug Metab Dispos. 2011. PMID: 21940904

2

Removal of imipenem and cilastatin by hemodialysis in patients with end-stage renal failure.

Konishi K, Suzuki H, Saruta T, Hayashi M, Deguchi N, Tazaki H, Hisaka A. Konishi K, et al. Among authors: hisaka a. Antimicrob Agents Chemother. 1991 Aug;35(8):1616-20. doi: 10.1128/AAC.35.8.1616. Antimicrob Agents Chemother. 1991. PMID: 1929334 Free PMC article.

3

Prediction of in vivo nonlinear first-pass hepatic metabolism of YM796 from in vitro metabolic data.

Iwatsubo T, Hisaka A, Suzuki H, Sugiyama Y. Iwatsubo T, et al. Among authors: hisaka a. J Pharmacol Exp Ther. 1998 Jul;286(1):122-7. J Pharmacol Exp Ther. 1998. PMID: 9655850

4

Carrier-mediated hepatic uptake of peptidic endothelin antagonists in rats.

Akhteruzzaman S, Kato Y, Kouzuki H, Suzuki H, Hisaka A, Stieger B, Meier PJ, Sugiyama Y. Akhteruzzaman S, et al. Among authors: hisaka a. J Pharmacol Exp Ther. 1999 Sep;290(3):1107-15. J Pharmacol Exp Ther. 1999. PMID: 10454484

5

Analysis of pharmacokinetic data provided in Japanese package inserts and interview forms focusing on urinary excretion of pharmacologically active species.

Ohno Y, Kusama M, Hisaka A, Yanagihara Y, Suzuki H. Ohno Y, et al. Among authors: hisaka a. Yakugaku Zasshi. 2006 Jul;126(7):489-94. doi: 10.1248/yakushi.126.489. Yakugaku Zasshi. 2006. PMID: 16819270 Free article.

6

General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs.

Ohno Y, Hisaka A, Suzuki H. Ohno Y, et al. Among authors: hisaka a. Clin Pharmacokinet. 2007;46(8):681-96. doi: 10.2165/00003088-200746080-00005. Clin Pharmacokinet. 2007. PMID: 17655375

7

General framework for the prediction of oral drug interactions caused by CYP3A4 induction from in vivo information.

Ohno Y, Hisaka A, Ueno M, Suzuki H. Ohno Y, et al. Among authors: hisaka a. Clin Pharmacokinet. 2008;47(10):669-80. doi: 10.2165/00003088-200847100-00004. Clin Pharmacokinet. 2008. PMID: 18783297

8

A proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert classifications in product labelling.

Hisaka A, Kusama M, Ohno Y, Sugiyama Y, Suzuki H. Hisaka A, et al. Clin Pharmacokinet. 2009;48(10):653-66. doi: 10.2165/11317220-000000000-00000. Clin Pharmacokinet. 2009. PMID: 19743887

9

Prediction of pharmacokinetic drug-drug interaction caused by changes in cytochrome P450 activity using in vivo information.

Hisaka A, Ohno Y, Yamamoto T, Suzuki H. Hisaka A, et al. Pharmacol Ther. 2010 Feb;125(2):230-48. doi: 10.1016/j.pharmthera.2009.10.011. Epub 2009 Dec 3. Pharmacol Ther. 2010. PMID: 19951720 Review.

10

Theoretical considerations on quantitative prediction of drug-drug interactions.

Hisaka A, Ohno Y, Yamamoto T, Suzuki H. Hisaka A, et al. Drug Metab Pharmacokinet. 2010;25(1):48-61. doi: 10.2133/dmpk.25.48. Drug Metab Pharmacokinet. 2010. PMID: 20208388 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters